PD-1 functions as PD-L1’s T-cell-inhibitory receptor, and both PD-L1 (CD274) and PD-L2 (CD273; also known as B7-DC) are expressed in cancer cells and APCs in the TME [134,135,136]. Here, CD80 is linked to cancer.